Stuart C. Gordon

40.8k citations
381 papers · 34k · 16 hit papers · h-index 74

Impact in

  • Hepatology top 0.01%
    • Hepatitis C virus research
    • Liver Diseases and Immunity
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Liver physiology and pathology
  • Epidemiology top 0.2%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 193
    • Liver Diseases and Immunity 44
    • Liver Disease and Transplantation 17
    • Hepatocellular Carcinoma Treatment and Prognosis 6
    • Hepatitis B Virus Studies 53
    • Liver Disease Diagnosis and Treatment 38

Stuart C. Gordon

365 papers receiving 32.2k citations

Stuart C. Gordon's Hit Papers

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 2019 · 1.1k citations
1.1k0+9+18Years since publication1k2k3k4k5k

Peers

Stuart C. Gordon
Comparison fields: 5 of 161
  • Hepatology 25k
  • Epidemiology 5.5k
  • Biological Psychiatry 87
  • Pharmacology 542
  • Immunology 682
Replace Mitchell L. Shiffman with:
Mitchell L. Shiffman United States
Ira M. Jacobson United States
Eugene R. Schiff United States
Antonio Craxı̀ Italy
Thomas Berg Germany
Janice K. Albrecht United States
Adrian M. Di Bisceglie United States
Graham R. Foster United Kingdom
Geoffrey M Dusheiko United Kingdom
John G. McHutchison United States
Stuart C. Gordon relative to Mitchell L. Shiffman United States Mitchell L. Shiffman's profile →
Citations per field
00.5×1.5×
Mitchell L. Shiffman · 1×
Citations per year

Countries citing papers authored by Stuart C. Gordon

Since Specialization
Citations

This map shows the geographic impact of Stuart C. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart C. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart C. Gordon more than expected).

Fields of papers citing papers by Stuart C. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart C. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart C. Gordon. The network helps show where Stuart C. Gordon may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart C. Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart C. Gordon Line = papers co-authored together Stuart C. Gordon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 381 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
Hit paper breakdown →
20015127
2
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
Hit paper breakdown →
19982948
3
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Hit paper breakdown →
20131503
4
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Hit paper breakdown →
20111341
5
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Hit paper breakdown →
20141121
6
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
Hit paper breakdown →
19981119
7
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
20191078
8
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Hit paper breakdown →
2014980
9
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Hit paper breakdown →
2016916
10
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Hit paper breakdown →
2013907
11
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
Hit paper breakdown →
2009891
12
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Hit paper breakdown →
2015699
13
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Hit paper breakdown →
2018588
14
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Hit paper breakdown →
2010570
15 2001551
16
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Hit paper breakdown →
2014482
17
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Hit paper breakdown →
2017453
18 2004410
19 2007376
20 2005331

About Stuart C. Gordon

Stuart C. Gordon is a scholar working on Hepatology, Epidemiology, Insect Science, Pharmacology and Health Information Management, having authored 381 papers that have together received 34k indexed citations. Recurring topics across this work include Hepatitis C virus research (193 papers), Hepatitis B Virus Studies (53 papers), Liver Diseases and Immunity (44 papers), Liver Disease Diagnosis and Treatment (38 papers), Liver Disease and Transplantation (17 papers), Insect-Plant Interactions and Control (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). The work is most often cited by research in Hepatology (25k citations), Epidemiology (5.5k citations), Biological Psychiatry (87 citations), Pharmacology (542 citations) and Immunology (682 citations). Stuart C. Gordon has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Janice K. Albrecht, John G. McHutchison, Mitchell L. Shiffman, Zachary D Goodman, Vinod K. Rustgi, Mei-Hsiu Ling, Kenneth J. Koury, Robert Reindollar, Michael Peter Manns and Eugene R. Schiff. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Journal of Viral Hepatitis and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact